small molecule

CALCIBIND

CELLULOSE SODIUM PHOSPHATE

Loss of exclusivityloss of exclusivity
CompanyMISSION PHARMACAL CO

Drug detail

Brand nameCALCIBIND
Active ingredientCELLULOSE SODIUM PHOSPHATE
Strength300GM/BOT
Dosage formPOWDER
RouteORAL
ModalitySmall molecule
FDA approvalOctober 1984
Marketing statusDISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

CALCIBIND patent cliff — loss of exclusivity — | CliffBio